Sostenere le imprese Il Programma GOL sostiene le imprese offrendo supporto nella ricerca di figure professionali
UK Medical Guide Mounjaro (tirzepatide) is a dual GLP-1 and GIP receptor agonist licensed in the UK for type 2 diabetes mellitus
The GLP-1 Gold Rush: What Weight-Loss Drug Marketing Reveals About the Future of Pharma Media The surge in GLP-1 weight-loss drugs has reshaped the healthcare landscape almost overnight
peroxisomal -oxidation is also important for metabolism of dicarboxylic acids generated via the -oxidation pathway -oxidation: a minor, but clinically significant, pathway for fatty oxidation initiated by microsomal -hydroxylation reactions, also involves the oxidation of dicarboxylic acids generated Ketone body: any of the compounds, -hydroxybutyrate, acetoacetate, and acetone, generated during hepatic ketogenesis from the substrate, acetyl-CoA Diabetic ketoacidosis (DKA): a condition of increased plasma ketone body concentration caused by excess adipose tissue fatty acid release and hepatic fatty acid oxidation resulting from unregulated glucagon release Following absorption of the products of lipid digestion, the resynthesis of TGs, cholesterol esters, and phospholipids occurs
Additionally, disease modifying properties of these medications are compelling
They found that a variant in the GLP1R gene (which encodes the receptor the drugs actually target) was associated with more GLP-1-related weight loss, which makes sense